Preoperative Carboplatin–Paclitaxel–Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study
Crossref DOI link: https://doi.org/10.1245/s10434-015-4371-0
Published Online: 2015-01-09
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guarneri, Valentina
Dieci, Maria Vittoria
Bisagni, Giancarlo
Boni, Corrado
Cagossi, Katia
Puglisi, Fabio
Pecchi, Annarita
Piacentini, Federico
Conte, PierFranco
Text and Data Mining valid from 2015-01-09